Achromobacter xylosoxidans Keratitis after Contact Lens Usage by Park, Jung Hyun et al.
Case Report
Achromobacter xylosoxidans Keratitis after Contact Lens Usage
   
Jung Hyun Park, Nang Hee Song, Jae Woong Koh
Department of Ophthalmology, Chosun University College of Medicine, Gwangju, Korea
pISSN: 1011-8942  eISSN: 2092-9382
Korean J Ophthalmol 2012;26(1):49-53
http://dx.doi.org/10.3341/kjo.2012.26.1.49
Achromobacter xylosoxidans is a gram-negative bacillus 
that belongs to the genus Alicaligenes. It is often confused 
with Pseudomonas aeruginosa, a Gram-negative bacillus 
that is commonly identified in an isolation process and is 
also called xylosoxidans due to its ability to oxidize xylose. 
Achromobacter xylosoxidans can exist in any contami-
nated place, though it is mainly found in soil and water. 
It rarely causes infection in humans but has been known 
to cause opportunistic infections in patients with tumors, 
hematologic disease, organ transplants, hypogammaglobu-
linemia, or acquired immunodeficiency syndrome (AIDS) 
[1]. Since Achromobacter sepsis from a diagnostic appa-
ratus was reported to have occurred in five patients at a 
Pennsylvania University Hospital in 1972, Achromobacter 
has drawn attention as a causative pathogen of nosocomial 
infection and for its reported resistance to various antibi-
otics [2-5]. In addition to sepsis, Achromobacter has also 
been reported to cause various infections such as men-
ingitis, pneumonia, urinary duct disease, and peritonitis. 
There have recently been several reports on extraocular 
infection caused by Achromobacter xylosoxidans. These 
infections occurred in patients with suppressed corneal 
immunity, such as patients with corneal transplantation 
or endophthalmitis. In this paper, we report two cases of 
Achromobacter xylosoxidans keratitis in healthy young 
women who had worn soft contact lenses for an extended 
period of time.
Case Reports
Case 1
A 36-year-old female patient visited our hospital com-
plaining of right ocular pain and reduced vision for the 
week before the visit. She had been diagnosed with right 
ocular keratitis in an ophthalmic clinic and took levofloxa-
cin (Cravit; Santen, Osaka, Japan) for a week. She had been 
wearing soft contact lenses for 20 years, had suffered from 
keratitis caused by the contact lenses, and had been treated 
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To report on Achromobacter xylosoxidans keratitis in two healthy patients who had worn contact lenses foran 
extended period of time. A 36-year-old female and a 21-year-old female visited our hospital with ocular pain 
and blurred vision. Both patients had a history of wearing soft contact lenses for over fve years with occasional 
overnight wear. At the initial presentation, a slit lamp examination revealed corneal stromal infiltrations and 
epithelial defects with peripheral neovascularization in both patients. Microbiological examinations were 
performed from samples of corneal scrapings, contact lenses, contact lens cases, and solution. The culture 
resulting from the samples taken from the contact lenses, contact lens cases, and solution were all positive for 
Achromobacter xylosoxidans. Confrming that the direct cause of the keratitis was the contact lenses, the frst 
patient was prescribed ceftazidime and amikacin drops sensitive to Achromobacter xylosoxidans. The second 
patient was treated with 0.3% gatifoxacin and fortifed tobramycin drops. After treatment, the corneal epithelial 
defects were completely healed, and subepithelial corneal opacity was observed. Two cases of Achromobacter 
xylosoxidans keratitis were reported in healthy young females who wore soft contact lenses. Achromobacter 
xylosoxidans should be considered a rare but potentially harmful pathogen for lens-induced keratitis in healthy 
hosts.
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several times. She had no medical history of ocular injury, 
surgery, or treatment with ophthalmic or systemic steroids. 
No abnormal finding was observed in the blood test. The 
patient’s corrected visual acuity was 20 / 20 in both eyes, 
and her intraocular pressure was 11 mmHg in the right eye 
and 16 mmHg in the left eye. Her right bulbar conjunctiva 
near the lesion had hyperemia, and a 0.5 × 0.7 mm corneal 
epithelial defect was seen with intra-stromal infiltration 
and peripheral neovascularization toward the 12 o’clock 
direction of the limbus (Fig. 1A). There were no abnormal 
findings in the lens, vitreous body, or retina. A bacteriolog-
ical test was conducted on the corneal scrapings, contact 
lenses, lens cases, and lens washing agent. The right cor-
neal ulcer was treated topically with gatifloxacin (Gatiflo; 
Seoul, Korea) with an initial one-hour interval and then a 
late reduced frequency; with 2% homatropine (Ocuhomap-
Fig. 1. (A) The slit-lamp photograph at the first visit revealed a 0.5 × 0.7 mm-sized round corneal epithelial defect with stromal infiltration. 
(B) Seven days after treatment, the corneal lesion exhibited complete epithelialization with subepithelial corneal opacity.
Fig. 2. (A) Multiple colonies were formed on the MacConkey agar, and each colony exhibited a non-pigmented, dome-shaped cluster. (B) 
Gram staining showed various sizes of Gram-negative bacilli (Gram stain, ×1,000).
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ine Eye; Samil, Seoul, Korea) three times a day; and with 
0.3% unpreserved hyaluronic acid (Hyalein mini, Santen).
Improved symptoms and corneal status were initially 
observed. However, the patient visited the hospital again 
three weeks later due to deteriorating symptoms. The size 
of the corneal epithelial defect increased to 2.0 × 3.2 mm 
at the location of the previous lesion, and the corneal intra-
stromal infiltration also increased. After bacterial cultiva-
tion in the first encounter, bacteria were inoculated and 
cultivated in MacConkey agar at an intermediate level in 
all the specimens (Fig. 2). Achromobacter xylosoxidans 
was identified using a Vitek 2 GN colorimetirc identifica-
tion card (Biomerieux Vitek 2 System, Hazelwood, MO, 
USA) and is known to be sensitive to amikacin, ceftazi-
dime, and tobramycin. Accordingly, the patient was treated 
with fortified ceftazidime and fortified amikacin with an 
initial one-hour interval and a late reduced frequency and 
also with 2% homatropine (Ocuhomapine Eye) and 0.3% 
hyaluronic acid (Hyalein mini). The symptoms gradually 
improved three days after treatment, and complete epithe-
lialization of the lesion was observed with corneal opacity 
on the sixth day after treatment (Fig. 1B). After 7 days, the 
patient was treated with fortified ceftazidime and fortified 
amikacin and 0.3% hyaluronic acid four times a day. Her 
corrected visual acuity in the right eye was 20 / 25.
Case 2
A 21-year-old female patient was transferred to our hos-
pital due to right ocular pain and reduced vision. She had 
been wearing soft contact lenses for five years. She had no 
medical history of ocular injury, surgery, or treatment with 
ophthalmic or systemic steroids. No abnormal finding was 
observed in the blood test. The patient’s corrected visual 
acuity was 20 / 30 in both eyes, and her intraocular pres-
sure was 15 mmHg in the right eye. Her right bulbar con-
junctiva near the lesion had hyperemia, and a 0.5 × 0.5 mm 
corneal epithelial defect was seen with interstitial infiltra-
tion and peripheral neovascularization toward the 7 o’clock 
direction (Fig. 3A). There were no abnormal findings in the 
lens, vitreous body, or fundus. A bacteriological test was 
conducted on her contact lenses, lens cases, and lens wash-
ing agent. Her right ocular bacterial ulcer was treated with 
gatifloxacin (Gatiflo), with an initial one-hour interval and 
a late reduced frequency; with 2% homatropine (Ocuho-
mapine Eye) three times a day, and 0.3% unpreserved 
hyaluronic acid (Hyalein mini) eight times a day. Culture 
results revealed the presence of Achromobacter xylosoxi-
dans. Therefore, we added fortified tobramycin with an 
initial one-hour interval and a late reduced dose four times 
a day to the previous eye drop prescription. Complete 
epithelialization of the lesion was observed with corneal 
opacity on the sixth day after treatment (Fig. 3B). The pa-
tient’s corrected right ocular visual acuity was 20 / 20.
Fig. 3. (A)  Slit-lamp photography at the first visit showed a 0.5 × 0.5 mm-sized, round corneal epithelial defect with stromal infiltration 
at the 7 o’clock direction. (B) Seven days after treatment, the corneal lesion showed complete epithelialization with subepithelial corneal 
opacity.
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Discussion
Achromobacter xylosoxidans is an anaerobic, Gram-
negative bacillus that has motility due to its peritrichous 
cilia. In 1971, Yabuuchi and Oyama [6] first reported it in a 
patient with chronic otitis media. A. xylosoxidans has been 
known to exist not only in humans as ear and intestinal 
microbial flora, but also in soil and water. Recently, noso-
comial infections from dialysis solutions, saline solutions, 
and humidifier solutions have been reported. These infec-
tions are especially known to cause opportunistic infection 
in patients with reduced immunity due to the presence of 
tumors, hematologic disease, organ transplants, hypogam-
maglobulinemia, AIDS, late renal failure, or cystic fibrosis 
[7-15].  
According to previous studies, Achromobacter xylosoxi-
dans is known to be sensitive to piperacillin, ceftazidime, 
imipenem, and trimethoprim-sulfamethoxazole; resis-
tant to aminoglycoside, ampicillin, aztreonam, and most 
cephalosporins; and sensitive/resistant to cefepime or 
ciprofloxacin. Reddy et al. [16] reported that ceftazidime 
and amikacin were the best drugs for initial treatment of 
infection with this organism. In their study, antibiotic sus-
ceptibility was 90% to ceftazidime and 70% to amikacin. 
Since the pathogen is resistant to many antibiotics and has 
many variations, it is important to select an appropriate 
antibiotic based on a sensitivity test after the spread and 
cultivation of the pathogen. Pathogens associated with op-
portunistic infections in hospitals have recently become 
isolated in keratitis caused by contact lens use. It is likely 
that wearing contact lenses causes hypoxia and increased 
carbon gas, by which lactic acid in the corneal epithelium 
increases and leads to a reduced rate of lactic acid degra-
dation in the corneal epithelium, an epithelial defect due 
to glycogen insufficiency in the corneal epithelium, and an 
increased possibility of pathogen invasion [17,18]. In addi-
tion, if biofilm is formed on the surface of the contact lens 
or its storage case, an appropriate environment for bacte-
rial proliferation results. This could lead to a reduced bac-
tericidal effect upon disinfection and increased resistance 
to members of the immune system such as antibodies or 
macrophages. It is also likely that the use of a contami-
nated saline solution, inappropriate disinfection, or direct 
contact with contaminated water increases the risk of 
corneal infection. For example, the use of extended-wear 
lenses, overnight lenses, poor maintenance of the contact 
lens case, reusing or topping off contact lens solution, 
and poor lens hygiene contribute to the contamination of 
contact lenses. In our case, the patients did not wash their 
hands before handling the contact lenses. Therefore, we 
suspect that the hands were contaminated by the pathogen, 
which then spread to the contact lenses, lens solution, and 
case through the contaminated hands. If Achromobacter 
xylosoxidans is suspected as a causative pathogen that 
causes corneal ulcers, a cultivation examination of the con-
tact lenses and washing agent, in addition to the specimens 
collected from the lesion, is required. Especially in cases 
of patients with penetrating keratoplasty, patients to whom 
steroids have been locally or systemically administered, 
and patients with low immunity, corneal ulcers caused by 
Achromobacter xylosoxidans should be considered. 
To the best of our knowledge, there are ten reported cas-
es of Achromobacter xylosoxidans keratitis in the related 
literature. Most of these reports focus on patients whose 
corneal immune systems became impaired after undergo-
ing keratoplasty or after applying steroid eye drops [19-
23]. Recently, Reddy et al. [16] reported on the outcome 
of treatment of Achromobacter xylosoxidans keratitis in 
patients with trauma, keratoplasty, and endophthalmitis. In 
their study, the symptoms of all patients except one were 
resolved with topical antibiotic therapy. Linke et al. [24] 
also reported a case of bilateral Achromobacter xylosoxi-
dans keratitis after LASIK. 
In the present case, it was suspected that keratitis was 
induced by contact lens usage. Therefore, microbiological 
examinations were performed on the corneal scrapings, 
contact lenses, contact lens cases, and lens-washing agents. 
The growth of Achromobacter xylosoxidans from all spec-
imens was confirmed, which made it possible to ascertain 
that the contact lenses were the direct cause of the kerati-
tis.
The occurrence of Achromobacter xylosoxidans keratitis 
may be underreported in the literature because of the dif-
ficulty of positively identifying the organism. Achromo-
bacter xylosoxidans share many morphologic similarities 
with other Gram-negative rods. Achromobacter xylosoxi-
dans keratitis in healthy people without risk factors is 
indeed rare. This notwithstanding, the organism should be 
considered a rare but potential pathogen for lens-induced 
keratitis in healthy hosts.
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